Simplicillium sinense sp. nov., a novel potential pathogen of tinea faciei
Frontiers in Microbiology · 12.05.2023 · 14
DOI: 10.3389/fmicb.2023.1156027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 12.05.2023. Verfasst von Qiu-Hong Yan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical Mycology Center, Department of Dermatology, Air Force Medical Center, Fourth Military Medical University, Beijing, China. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
Simplicillium species are widely distributed with a broad spectrum of hosts and substrates. Generally, these species are entomopathogenic or mycoparasitic. Notably, some isolates of Simplicillium lanosoniveum and Simplicillium obclavatum were obtained from human tissues. In this study, two fungi were isolated from the annular itchy patch of infected skin of a 46-year-old man with diabetes mellitus. Based on a combination of morphological characteristics and phylogenetic analysis, a novel species, Simplicillium sinense , was introduced herein. It morphologically differs from the remaining Simplicillium in the size of phialides and conidia. Additionally, it grows slowly on YPD at 37°C. Antimicrobial susceptibility testing presented that this fungus is resistant to most azole antifungals. Therefore, the diagnosis of tinea faciei was made, and after 2 weeks of being treated with oral terbinafine (250 mg, once a day) and topical terbinafine cream for 1 month, the rash was mainly resolved and no recurrence happened after 6 months of follow-up. Herein, Simplicillium sinense was introduced as a new fungal taxon. Meanwhile, a case of superficial infection caused by S. sinense was reported. So far, it is the third Simplicillium species obtained from human tissue. Meanwhile, terbinafine is recommended as the first-line antifungal treatment against Simplicillium infection.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Mycology Center, Department of Dermatology, Air Force Medical Center, Fourth Military Medical University, Beijing, China.
- State Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
- Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China.
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Yan, Q. H., Ni, Q. R., Gu, W. J., Liu, H. W., Yuan, X. Y., & Sun, J. Z. (2023). Simplicillium sinense sp. nov., a novel potential pathogen of tinea faciei. Frontiers in Microbiology, 14. https://doi.org/10.3389/fmicb.2023.1156027
Vancouver
Yan QH, Ni QR, Gu WJ, Liu HW, Yuan XY, Sun JZ. Simplicillium sinense sp. nov., a novel potential pathogen of tinea faciei. Frontiers in Microbiology. 2023;14. doi:10.3389/fmicb.2023.1156027
BibTeX
@article{Yan2023,
author = {Yan, Qiu-Hong and Ni, Qing-Rong and Gu, Wei-Jie and Liu, Hong-Wei and Yuan, Xiao-Ying and Sun, Jing-Zu},
title = {Simplicillium sinense sp. nov., a novel potential pathogen of tinea faciei},
journal = {Frontiers in Microbiology},
year = {2023},
volume = {14},
doi = {10.3389/fmicb.2023.1156027}
}
EUVIMED